v3.25.1
Fair Value of Financial Instruments
 3 Months Ended
Mar. 30, 2025
Fair Value Disclosures [Abstract]  
Fair Value of Financial Instruments Fair Value of Financial Instruments
The Company measures certain financial instruments at fair value. The fair value hierarchy consists of three levels:
•Level 1 fair values are based on quoted market prices in active markets for identical assets or liabilities that the entity has the ability to access;
•Level 2 fair values are those based on quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities;
•Level 3 fair values are based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.
The Company had the following assets and liabilities measured at fair value in its Consolidated Balance Sheets (excluding assets for which the fair value is measured using net asset value per share):
Fair Value Measurements Using:
Fair
Value		Quoted
Prices in
Active
Markets
for
Identical
Assets
(Level 1)		Significant
Other
Observable
Inputs
(Level 2)		Significant
Unobservable
Inputs
(Level 3)
March 30, 2025
Assets:
Available-for-sale securities$10.7 $10.7 $— $— 
Derivatives5.0 — 5.0 — 
Total assets$15.7 $10.7 $5.0 $— 
Liabilities:
Derivatives$2.1 $— $2.1 $— 
Total liabilities$2.1 $— $2.1 $— 
March 31, 2024
Assets:
Available-for-sale securities$0.8 $0.8 $— $— 
Derivatives8.5 — 8.5 — 
Total assets$9.3 $0.8 $8.5 $— 
Liabilities:
Derivatives$2.9 $— $2.9 $— 
Option agreement1.7 — — 1.7 
Total liabilities$4.6 $— $2.9 $1.7 
December 29, 2024
Assets:
Available-for-sale securities$0.6 $0.6 $— $— 
Derivatives9.7 — 9.7 — 
Total assets$10.3 $0.6 $9.7 $— 
Liabilities:
Derivatives$1.7 $— $1.7 $— 
Total Liabilities$1.7 $— $1.7 $— 
The Company's derivatives primarily consist of foreign currency forward and option contracts. The Company uses current forward rates of the respective foreign currencies to measure the fair value of these contracts. There were no changes in these valuation techniques during the three months ended March 30, 2025. There were no material changes to fair value measurements of the Company's financial instruments which use significant unobservable inputs (Level 3) for three months ended March 31, 2024.
Other Fair Value Measurements
The Company's financial instruments include cash and cash equivalents, accounts receivable, short-term borrowings, accounts payable and certain Accrued liabilities. At March 30, 2025, March 31, 2024, and
December 29, 2024, the carrying cost of these instruments approximated their fair value. The Company's financial instruments at March 30, 2025, March 31, 2024, and December 29, 2024 also include certain assets and liabilities measured at fair value, as described above. See Note 8, Long-Term Debt and Other Financing, for the fair value of the Company's outstanding debt.